Peer-Reviewed Publications & Textbooks

Refereed Journal Articles

  1. Ceacareanu AC, Brown GW, Moussa HA, Wintrob ZAP. Application of a Pharmacokinetic Model of Metformin Clearance in a Population with Acute Myeloid Leukemia. J Res Pharm Pract. 2018;7(1):41-45. PubMed Link
  2. Ceacareanu AC, Nimako GK, Wintrob ZAP. Missing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?. J Res Pharm Pract. 2017;6(3):145-150. PubMed Link
  3. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer. Data Brief. 2017;11:459-468. Published 2017 Feb 22. doi:10.1016/j.dib.2017.02.038 PubMed Link
  4. Wintrob ZA, Hammel JP, Nimako GK, et al. Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and breast cancer. Data Brief. 2017;11:446-458. Published 2017 Feb 22. doi:10.1016/j.dib.2017.02.045 PubMed Link
  5. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer. Data Brief. 2017;11:413-427. Published 2017 Feb 22. doi:10.1016/j.dib.2017.02.044 PubMed Link
  6. Wintrob ZA, Hammel JP, Nimako GK, et al. Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patients. Data Brief. 2017;11:391-402. Published 2017 Feb 16. doi:10.1016/j.dib.2017.02.031 PubMed Link
  7. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer. Data Brief. 2017;11:382-390. Published 2017 Feb 21. doi:10.1016/j.dib.2017.02.037 PubMed Link
  8. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer. Data Brief. 2017;11:331-348. Published 2017 Feb 20. doi:10.1016/j.dib.2017.02.028 PubMed Link
  9. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer. Data Brief. 2017;11:277-283. Published 2017 Feb 20. doi:10.1016/j.dib.2017.02.027 PubMed Link
  10. Wintrob ZA, Hammel JP, Nimako GK, Gaile DP, Forrest A, Ceacareanu AC. Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer. Data Brief. 2017;11:183-191. Published 2017 Feb 13. doi:10.1016/j.dib.2017.02.017 PubMed Link
  11. Wintrob ZA, Hammel JP, Nimako GK, et al. Circulating adipokines data associated with insulin secretagogue use in breast cancer patients. Data Brief. 2016;10:238-247. Published 2016 Nov 22. doi:10.1016/j.dib.2016.11.060 PubMed Link
  12. Wintrob ZA, Hammel JP, Khoury T, et el. Insulin use, adipokine profiles and breast cancer prognosis. Cytokine. 2016;89:45-61. Published 2016 Nov 20. doi:10.1016/j.cyto.2016.10.017 PubMed Link
  13. Nimako GK, Wintrob ZAP, Sulik DA, Donato JL, Ceacareanu AC. Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies. J Pharmacy Practice. 2016;30:185–194. Published 2016 Jan 25. doi:10.1177/0897190015627255 PubMed Link
  14. Wintrob ZAP. Should Pharmacokinetic Safety Challenges Prevent Metformin Use in Patients With Cancer? J Pharmacy Practice, 2015;28:48–49. Published 2015 Feb 24. doi:10.1177/0897190014559392 PubMed Link
  15. Wintrob ZAP, Oppong EK, Foster M, et al. Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model. Cytokine. 2014;67:102-106. Published 2014 Mar 29. doi:10.1016/j.cyto.2014.02.011 PubMed Link
  16. Zou J, Jafr G, Themistou E, Yap Y, Wintrob ZAP, Alexandridis P, Ceacareanu AC,  Cheng C. pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization. Published 2011 Mar 11. Chem Communication. 2011;47:4493-4495. doi:10.1039/C0CC05531J PubMed Link

Conference Proceedings

    National & International

  1. Kurzrock R, Goldberg R, Ceacareanu AC, Wintrob ZAP. The impact of new oncology drugs on disability and health care spending: an assessment of real-world evidence. National Cancer Center Network Annual Conference, Orlando, FL. Mar 2019.
  2. Asma H, Miller L, Wintrob ZAP, Tian M, Hageman-Blair R. Drosophila embryo structure from transcriptome: 3-dimensional data recovery post Drop-seq profiling using 20 genes. 11th annual RECOMB/ISCB Conference on Regulatory & Systems Genomics. New York NY. Dec 2018. doi: 10.13140/RG.2.2.29647.94889 ResearchGate
  3. Shashaty G, Yi S, Wintrob ZAP, Nimako GK, Ceacareanu AC. Growth factor correlations in women with breast cancer and diabetes mellitus: the impact of metformin and statin therapy. American Society of Health-System Pharmacists Annual Meeting. Orlando FL. Dec 2017.
  4. Lin LH, Yi S, Wintrob ZAP, Nimako GK, Fu HW, Shah AB, Ceacareanu AC. Growth factor correlations in women with breast cancer and diabetes mellitus: the impact of metformin and statin therapy. American Society of Health-System Pharmacists Annual Meeting. Orlando FL. Dec 2017. doi: 10.13140/RG.2.2.33138.81603 ResearchGate
  5. Slavinsky A, Wintrob ZAP, Nimako GK, Frohnapple CB, Miller DS, Ceacareanu AC. Pravastatin in patients with diabetes mellitus and solid tumors – are all statins created equal? American College of Clinical Pharmacy. Pheonix AZ. Oct 2017. doi: 10.13140/RG.2.2.32071.80807 ResearchGate
  6. Yin KQ, Nimako GK, Wintrob ZAP, Ceacareanu AC. (2016) The pharmacology, clinical efficacy and safety of vitamin D supplementation in cancer patients. American Society of Health-system Pharmacists Annual Meeting. Las Vegas, NV. Dec 2016.
  7. Wintrob ZAP, Hammel JP, Khoury T, Nimako GK, Fu HW, Fayazi ZS, Gaile DP, Forrest A, Ceacareanu AC. Pharmacotherapy, cytokine profiles, and prognosis in women with diabetes mellitus and breast cancer. International Immunology Congress. Bucharest, Romania. Oct 2016.
  8. Frohnapple CB, Sulik DA, Wintrob ZAP, Ceacareanu A. Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lung Cancer and Diabetes Mellitus. American Society of Health-System Phamracists Annual Meeting. Anaheim CA. Dec 2014. doi: 10.13140/2.1.1702.8162 ResearchGate
  9. Sulik DA, Frohnapple CB, Wintrob ZAP, Ceacareanu A. Pharmacotherapy and beyond: Who has the gut to make it through colorectal cancer? American Society of Health-System Phamracists Annual Meeting. Anaheim CA. Dec 2014. ResearchGate
  10. Wintrob ZAP, Chuang HC, Miller DS, Rabey JL, Bui TQ, Amsler ME, Salsabili M, Ford LA, Wetzler M, Ceacareanu AC. Missing the benefit of metformin in AML: A problem of contrast. American Association for Cancer Research 104th Annual Meeting. Washington DC. Apr 2013. doi: 10.1158/1538-7445.AM2013-LB-17 ResearchGate
  11. Wintrob ZAP, Fung MC, Bear MD, Fyles AW, Bui TQ, Brown GW, Ceacareanu AC. Could pharmacy students identify risk for lactic acidosis after contrast dye administration in leukemia patients treated with metformin? European Association of Faculties of Pharmacy, Ljubljana, Slovenia. May 2014.
  12. Wintrob ZAP, Radpasand H, Elmeshad MH, Barima A, Rabey JL, Chmiel KA, Fayazi ZS, Otvos L, Surmacz E, Faitar S, Ceacareanu AC. Adiponectin receptor mediated weight regulation: an inflammation-independent mechanism? Experimental Biology Annual Meeting. Boston MA. Apr 2013. ResearchGate
  13. Wintrob ZAP, Oppong EK, Tse YC, Welt JM, Boateng HR, Drumea IM, Martorana M, Irlam J, LeVea CM, Faitar SL, Ceacareanu AC. Inflammation and sexual dimorphism in development of insulin resistance: a dual animal model comparison. Experimental Biology Annual Meeting. Boston MA. Apr 2013. ResearchGate
  14. Fung MC, Wintrob ZAP, Brown GW, Wetzler M, Ceacareanu AC. Modeling of lactic acidosis risk post contrast dye in leukemia patients treated with metformin. American Society of Health-System Pharmacists Annual Meeting. Orlando FL. Dec 2013. ResearchGate
  15. Wintrob ZAP, Chuang HC, Miller DS, Rabey JL, Bui TQ, Amsler ME, Salsabili M, Ford LA, Wetzler M, Ceacareanu AC. Missing the benefit of metformin in acute myeloid leukemia: a problem of contrast. American Association for Cancer Research Annual Meeting. Washington DC. Apr 2013.
  16. Ceacareanu AC, Hong CC, Jackowiak CM, Zhang YL, Khoury T, Nimako GK, Ekonomidis D, Wintrob ZAP, Kossoff E, Kublas TM, Forrest A. Use of insulin sensitizers is associated with better hormone-receptor pattern and improved breast cancer outcomes. American Association for Cancer Research 103rd Annual Meeting. Chicago IL. Apr 2012. doi: 10.1158/1538-7445.AM2012-LB-329 ResearchGate
  17. Miller DS, Wintrob ZAP, Ceacareanu AC. Lipid management and Prostate Cancer Outcomes in Patients with Type 2 Diabetes Mellitus. American Society of Health-System Pharmacists Annual Meeting. Las Vega NV. Dec 2012. ResearchGate
  18. Bui TQ, Chmiel K, Wintrob ZAP, Rodman H, Li A, Ford LA, Wetzler M, Ceacareanu AC. Effect of pre-existing statin therapy on acute myeloid leukemia prognosis. American Society of Health-System Pharmacists Annual Meeting. Las Vegas NV. Dec 2012. ResearchGate
  19. Hong CC, Ambrosone C, Ceacareanu AC, Wintrob ZAP, Kokolus KM, Davis W, Bovbjerg DH, Jenkins FJ, Edge S, Kulkarni SM, O’Connor TL. Changes in circulating hormone levels and weight among women with early stage breast cancer. 3rd North American Congress of Epidemiology. Montreal QC. Jun 2011. ResearchGate
  20. Faitar SL, Vokes J, Belko KE, Wintrob ZAP. Biochemical and immunocytochemical analysis of proteins transiently associated with the chromosomal passenger complex during mitosis. Experimental Biology Annual Meeting. Washington DC. Apr 2011. ResearchGate
  21. Fu HW, Wintrob ZAP, Martens CJ, Hong CC, Ceacareanu AC. Could Cholesterol drugs modulate inflammation in type 2 diabetics with breast cancer? American Society of Health-System Pharmacists Annual Meeting. Anaheim CA. Dec 2010. ResearchGate
  22. Ceacareanu AC, Hong CC, Elgebaly M, Epstein M, Wintrob ZAP, Kossoff E, Yeow D, Boateng HR, Welt JM, Fu HW, Wightman S, Shah AB, Ng PW, Liu D., Forrest A. Diabetes pharmacotherapy: A potential modifier of breast cancer prognosis? American Association for Cancer Research 101st Annual Meeting. Washington DC. Apr 2010. doi: 10.1158/1538-7445.AM10-LB-421 ResearchGate

    Local & Regional

  1. Lin LH, Yi S, Wintrob ZAP, Nimako GK, Ceacareanu AC. Statin treatment and growth factor levels in diabetes patients with newly diagnosed breast cancer. New York State Chapter ACCP Annual Clinical Meeting. Syracuse NY. Oct 2017.
  2. Yin KQ, Wintrob ZAP, Lin LH, Nimako GK, Kapoor S, Abdelrahman N, Ceacareanu AC. Impact of statin and beta-blocker type on head and neck cancer outcomes. New York State Chapter ACCP Annual Clinical Meeting. Rochester NY. Oct 2016.
  3. Abdelrahman N, Wintrob ZAP, Kapoor S, Yin KQ, Lin LH, Ceacareanu AC. Metformin attenuates the detrimental effects of insulin in head and neck cancer. Collegiate Science and Technology Entry Program. Buffalo NY. May 2016. doi: 10.13140/RG.2.2.24650.98246 ResearchGate
  4. Yin KQ, Wintrob ZAP, Lin LH, Nimako GK, Kapoor S, Abdelrahman N, Ceacareanu AC, Impact of statin and beta-blocker type on head and neck cancer outcomes. New York State Chapter of the American College of Clinical Pharmacy Annual Meeting. Rochester NY. Nov 2016. doi: 10.13140/RG.2.2.12068.07048 ResearchGate
  5. Brown GW, Moussa H, Wintrob ZAP, Bear MD, Fyles AW, Alin A, Ford L, Ceacareanu AC. Metformin and renal function after administration of contrast media in patients with AML: a pharmacokinetic assessment. 55th NYSCHP Annual Assembly. Saratoga Springs NY. Apr 2016.
  6. Brown GW, Moussa H, Wintrob ZAP, Bear M, Fyles A, Ford LA, Ceacareanu AC. Metformin and renal function after administration of contrast dye in patients with acute myeloid leukemia: a pharmacokinetic assessment. Annual SUNY Undergraduate Research Conference. Cobleskill NY. Apr 2016.
  7. Donato JL, Nimako GK, Wintrob ZAP, Sulik DA, Ceacareanu AC. Relationship between GERD-associated comorbidities and gastrointestinal cancer outcomes. Collegiate Science and Technology Entry Program. Buffalo NY. Jan 2015. doi: 10.13140/RG.2.2.32200.72965 ResearchGate
  8. McKenzie A, Wintrob ZAP, Elmeshad M, Rabey J, Chmiel KA, Radpasand H, Barima A, Fayazi ZS, Ceacareanu AC. Effect of estrogen on the development of fatty liver in high fat fed SCID mice. Collegiate Science and Technology Entry Program Symposium. Buffalo NY. Jan 2014.
  9. Yu Y, Zou J, Jafr G, Wintrob ZAP, Themistou E, Alexandridis P, Ceacareanu AC, Cheng C. Synthesis, Characterization, and Biomedical Assessment of pH-Sensitive Brush Polymer-Drug Conjugates for Cancer Therapy. Symposium on Research in Chemical and Biological Engineering. Buffalo NY. Oct 2010.

Presentations

  1. Kurzrock R, Goldberg R, Ceacareanu AC, Wintrob ZAP. The impact of new oncology drugs on disability and health care spending: an independent assessment of real world evidence. National Comprehensive Cancer Network Annual Conference. Orlando FL. Mar 2019.
  2. Invited Speaker: Wintrob ZAP. Who is Afraid of Biostats? Seminar presented at the
    University of Bucharest. Bucharest, Romania. Dec 2016.
  3. Invited Speaker: Wintrob ZAP. Pharmacokinetic Safety of Metformin in Patients with Leukemia and Diabetes. 1st Annual Conference of the International
    Society of Regenerative Medicine and Surgery. Bucharest, Romania. May 2015.

Textbooks

  1. Ceacareanu AC, Wintrob ZAP. Pharmacokinetic Consideration in Oncology. In: Cohen H eds. Casebook in Clinical Pharmacokinetics and Drug Dosing. 1st ed. Columbus OH: McGraw-Hill Education. 2015.